A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD
- 28 June 2008
- journal article
- review article
- Published by Hindawi Limited in International Journal of Clinical Practice
- Vol. 62 (8), 1219-1236
- https://doi.org/10.1111/j.1742-1241.2008.01807.x
Abstract
Chronic obstructive pulmonary disease (COPD) is a leading cause of death in the USA, and represents a major health, social and economic burden. COPD is underdiagnosed and often misdiagnosed, which likely contributes to the continuing increases in the prevalence, morbidity and mortality associated with this disease. This is unfortunate because whereas COPD cannot be cured, it can be treated effectively, particularly during the earlier stages of the disease. Evidence-based guidelines, developed to assist in the prevention, diagnosis and management of COPD, are available to healthcare professionals interested in learning more about COPD. These guidelines are updated and revised on a regular basis to reflect recent advances in our understanding of the pathophysiology of and treatments available for COPD. Nevertheless, primary-care physicians have reported a lack of awareness of the fundamental concepts underpinning the optimal treatment and management of COPD presented in the guidelines. Thus, the objective of this article is to summarise key physiologic, diagnostic and management concepts provided in the most recent update of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, which were published in November 2006.Keywords
This publication has 96 references indexed in Scilit:
- Profiling serum biomarkers in patients with COPD: associations with clinical parametersThorax, 2007
- Impact of Pneumococcal Vaccination on Pneumonia Rates in Patients with COPD and AsthmaJournal of General Internal Medicine, 2007
- Misdiagnosis of COPD and Asthma in Primary Care Patients 40 Years of Age and OverJournal of Asthma, 2006
- Outcomes and health‐related quality of life following hospitalization for an acute exacerbation of COPDRespirology, 2005
- Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease?Current Opinion in Pulmonary Medicine, 2005
- Effects of Pulmonary Rehabilitation on Dyspnea, Quality of Life, and Healthcare Costs in CaliforniaJournal of Cardiopulmonary Rehabilitation, 2004
- Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary diseaseEuropean Respiratory Journal, 2003
- Patients at High Risk of Death after Lung-Volume–Reduction SurgeryNew England Journal of Medicine, 2001
- A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary diseaseThorax, 2001
- The natural history of chronic airflow obstruction.BMJ, 1977